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Background: A growing body of evidence suggests that Mycobacterium tuberculosis (Mtb) uses the host’s
cholesterol as a source of carbon and energy during infection. Strains defective in cholesterol transport or
degradation exhibit attenuated growth in activated macrophages and diminished infectivity in animal
models. The aim of this study was to evaluate intracellular replication of a cholesterol degradation-deficient
Mtb mutant in human macrophages (MØ) in vitro and assess the functional responses of Mtb mutant-
infected MØ.
Results: A mutant Mtb H37Rv strain containing an inactivated kstD gene (ΔkstD), which encodes 3-
ketosteroid 1(2)-dehydrogenase (KstD), was previously prepared using the homologous recombination-based
gene-replacement technique. A control strain carrying the kstD gene complemented with an intact kstD
was also previously constructed. In this study, human resting MØ were obtained after overnight
differentiation of the human monocyte-macrophage cell line THP-1. Resting MØ were further activated with
interferon-γ (IFN-γ). The ability of the kstD-defective Mtb mutant strain to replicate intracellularly in human
MØ was evaluated using a colony-forming assay. Nitric oxide (NO) and reactive oxygen species (ROS)
production by MØ infected with wild-type or ΔkstD strains was detected using Griess reagent and
chemiluminescence methods, respectively. The production of tumor necrosis factor-α and interleukin-10 by
MØ after infection with wild-type or mutant Mtb was examined using enzyme-linked immunosorbent
assays.
We found that replication of mutant Mtb was attenuated in resting MØ compared to the wild-type or
complemented strains. Moreover, the mutant was unable to inhibit the NO and ROS production induced
through Toll-like receptor 2 (TLR2) signaling in infected resting MØ. In contrast, mutant and wild-type Mtb
behaved similarly in MØ activated with IFN-γ before and during infection.
Conclusions: The Mtb mutant ΔkstD strain, which is unable to use cholesterol as a source of carbon and
energy, has a limited ability to multiply in resting MØ following infection, reflecting a failure of the ΔkstD
strain to inhibit the TLR2-dependent bactericidal activity of resting MØ.
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Alveolar macrophages (MØ) represent the host’s first
line of defense against Mycobacterium tuberculosis
(Mtb). Phagocytosed Mtb bacilli are subjected to deg-
radation via oxygen-dependent and -independent
mechanisms. In the oxygen-dependent mechanism, MØ
produce a variety of powerful mediators such as reactive
oxygen species (ROS) and reactive nitrogen intermediates
(RNI) that kill bacteria [1,2].
The first step in the activation of innate host defenses
against Mtb is the recognition of the pathogen. Host
receptors involved in bacterial recognition and phagocyt-
osis include complement receptors and pattern recogni-
tion receptors. Among the latter category are Toll-like
receptors (TLRs), which mediate stimulation of the im-
mune cells. TLR2, in particular, is known to be involved
in the recognition of Mtb. After interaction of a specific
structure of the mycobacterial cell wall with TLR2, a sig-
naling pathway cascade is initiated in which interleukin
1 receptor associated kinase-1 and −4 (IRAK-1/4) associ-
ate with TLR2 via the adaptor protein MyD88. IRAK-1/4
then phosphorylate and activate the protein TRAF-6
(tumor necrosis factor receptor-associated factor-6),
which in turn activates other signaling proteins, including
mitogen-activated protein kinases (MAPKs), phosphoinositide
3-kinase, protein kinase C, and nuclear factor κB. This
leads to the transcription of genes involved in the produc-
tion of nitric oxide (NO) and various cytokines, such as
interleukin (IL)-1β, tumor necrosis factor-α (TNF-α),
IL-10 and IL-12, and promotes activation of the NADPH
oxidase complex, which is responsible for ROS production
[2-27]. In the context of initial infection, MØ encounters
Mtb prior to being stimulated with the Th1 cytokine
interferon-γ (IFN-γ). However, full activation of MØ anti-
microbial capacity and antigen-presentation function only
occurs after stimulation with IFN-γ [8].
During infection, Mtb adapts to different nutrient
conditions to utilize fatty acids, which are alternative car-
bon and energy sources for tubercle bacilli. It is generally
accepted that Mtb can use cholesterol as a source of carbon
and energy. The full suite of genes required for cholesterol
degradation has been identified in the Mtb genome, and
the inactivation of cholesterol uptake by disruption of the
ABC-like transport system has been shown to affect cho-
lesterol degradation [9]. A similar effect was observed
following disruption of 3-ketosteroid 1 (2)-dehydrogenase
(KstD), 3-ketosteroid 9OH-hydroxylase (KshA/KshB), and
the iron-dependent extradiol dioxygenase (HsaC) key
enzymes involved in opening the steroid ring structure
[10-12]. We have previously shown that tubercle bacilli can
accumulate cholesterol in the free-lipid zone of their cell
walls [10]. We have also demonstrated that Mtb utilizes
cholesterol via the androstenedione/androstadienedione
pathway (AD/ADD) using KstD, which initiates steroid ringdegradation through transhydrogenation of 3-keto-4-ene
steroids to 3-keto-1,4-diene steroids and that KstD is an
essential enzyme in this process [10,13]. The Mtb ΔkstD
strain lacking functional KstD accumulates non-toxic
cholesterol degradation intermediates, AD and 9OHAD
(9a-hydroxy-4-androstene-3,17-dione) [10], and is unable
to grow on minimal medium supplemented with choles-
terol as a sole carbon and energy source. However, the rela-
tionship between the altered growth of the ΔkstD mutant
strain and the possible attenuation of the infection process
has not been previously described.
Here, we evaluated the ability of an Mtb strain lacking
a functional copy of the kstD gene to grow in human
MØ. The functional activity of MØ against the parental
Mtb H37Rv strain and the ΔkstD mutant strain was
compared by examining the production of NO, ROS,
TNF-α and IL-10 by resting and IFN-γ-activated MØ.
Methods
Chemicals and antibodies
RPMI-1640 medium containing 1 mM sodium pyruvate,
Dulbecco’s phosphate-buffered saline (D-PBS) and Hanks’
balanced salt solution (HBSS) were purchased from Gibco
(Scotland). Middlebrook OADC (oleic acid albumin dex-
trose catalase) enrichment, Middlebrook 7H9 broth, and
Middlebrook 7H10 agar were obtained from Becton
Dickinson (USA). IFN-γ, phorbol 12-myristate 13-acetate
(PMA), bovine serum albumin (BSA), fluorescein isothio-
cyanate (FITC), Tween-20, Tween-80, IRAK1/4 inhibitor,
37% formaldehyde solution (FA), horseradish peroxidase
(HRP), 2-mercaptoethanol (2-ME) and luminol were
purchased from Sigma-Aldrich (USA). Human type AB
serum (off-clot) and fetal bovine serum (FBS) were
purchased from PAA-The Cell Culture Company (Austria).
Mouse IgG2a anti-human TLR2 (sodium azide-free), phyco-
erythrin (PE)-conjugated mouse anti-TLR2 (IgG2a), and PE-
conjugated mouse IgG2aκ isotype control were obtained
from Imgenex (USA). FITC-conjugated mouse anti-human
CD14 (IgG2aκ) and PE-conjugated anti-human CD11b
(IgG1κ) were purchased from BD Pharmingen (USA).
Human TNF-α and human IL-10 Quantikine enzyme-
linked immunosorbent assay (ELISA) kits were purchased
from R&D Systems (USA).
Bacterial strains and growth conditions
All strains used in this study were based on M. tuberculosis
H37Rv (ATCC) and were maintained on Middlebrook
7H10 agar or 7H9 broth supplemented with 10% OADC
enrichment and 25 μg/ml kanamycin, as required. For
growth on media supplemented with defined carbon
sources, strains were grown in minimal medium sup-
plemented with 0.01% cholesterol, as described previ-
ously [9]. The engineering of the Mtb strain deficient
for the KstD enzyme (ΔkstD), and ΔkstD complemented
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previously [10]. Wild-type, mutant, and complemented
bacterial strains were prepared for infection by growing
in roller bottles in Middlebrook 7H9 broth containing
10% OADC enrichment and 0.05% Tween-80 for 4–6
days to reach an optical density at 600 nm (OD600) of 1.
A portion of the bacterial culture (approximately 1 × 109
bacilli/ml) was suspended in Middlebrook 7H9 broth
and labeled with 100 μg/ml of FITC by incubating for
2 hours at room temperature with gentle agitation in
the dark. FITC-labeled bacteria were washed once with
Middlebrook 7H9 broth supplemented with 4% BSA
and then twice with Middlebrook 7H9 broth without
BSA. Unlabeled and FITC-labeled bacteria were divided
into equal portions and stored at -85°C. After 1 week, a
portion of bacteria was thawed and colony-forming
assays were used to determine the number of bacterial
colony-forming units (CFUs).
Cells culture
The human monocyte-macrophages cell line THP-1
(ATCC TIB-202, USA) was maintained in culture
medium (CM) consisting of RPMI-1640 supplemented
with 1 mM sodium pyruvate, 10% FBS, 0.05 mM 2-ME,
100 U/ml of penicillin and 100 μg/ml of streptomycin at
37°C in a humidified 5% CO2 environment. THP-1 cells
were passaged every 3–4 days.
Undifferentiated THP-1 cells (monocytes) were
distributed into 24- and 96-well plates and differentiated
into macrophages (resting MØ) by culturing for 24 hours
(37°C, 5% CO2) with PMA (20 ng/ml), as described pre-
viously by others [14-16]. The macrophage-like pheno-
type of the cells was confirmed by assessing CD14
expression using flow cytometry (see below). The ability
of resting MØ to adhere to plastic dishes was examined
under a light microscope. IFN-γ-activated MØ were
prepared by incubating resting MØ with 20 ng/ml of
IFN-γ in CM for 24 hours (37°C, 5% CO2). Resting MØ
and IFN-γ-activated MØ were infected with bacteria and
cultured in CM without antibiotics. IFN-γ (20 ng/ml)
was added to cultures of IFN-γ-activated MØ.
Flow cytometry analysis
CD14 surface expression on monocytes and resting MØ
was assessed by staining the cells (1 × 105) with 10 μg/ml
of a FITC-conjugated monoclonal antibody (mAb) against
CD14 or isotype control (IgG2a; 10 μg/ml) for 30 minutes
at 4°C. Before staining with anti-TLR2 mAb, crystallizable
fragment receptors (FcRs) were blocked in D-PBS
containing 10% human AB serum for 15 minutes at room
temperature to prevent nonspecific antibody binding.
Subsequently, cells were washed twice in D-PBS
containing 1% FBS. Resting MØ and IFN-γ-activated MØ
(1 × 105 cells) were stained with 10 μg/ml of a PE-conjugated anti-TLR2 mAb or isotype control (IgG1;
10 μg/ml). A concentration of anti-TLR2 mAb sufficient
to completely block the expression of TLR2 on cells was
determined in preliminary experiments by adding differ-
ent mAb concentrations (10, 25, and 35 μg/ml) to MØ
and incubating for 1 hour (37°C/5% CO2). MØ were then
stained with PE-conjugated anti-TLR2 mAb or isotype
control, as described above.
All stained cells were washed twice, resuspended in
200 μl of D-PBS containing 1% FBS, 1% FA and sodium
azide, and stored at 4°C until FACS (fluorescence-activated
cell sorting) analysis. All samples were examined with a
FACS LSR II BD flow cytometer (Becton Dickinson, USA)
equipped with BD FACS Diva Software. The results were
presented as median fluorescence intensity (MFI), which
correlates with the surface expression of the target
molecule.
MØ infection
Bacteria were thawed, washed twice in RPMI-1640
medium, and then opsonized (or not) by incubating
with 20% human serum AB in RPMI-1640 medium
for 30 minutes at 37°C with gentle agitation. There-
after, bacteria were washed once with RPMI-1640
medium. Opsonized and non-opsonized Mtb were
suspended in CM, and clumps were disrupted by
multiple passages through a 25-gauge needle. Serial
dilutions of bacteria were prepared in CM.
Resting MØ and IFN-γ-activated MØ were infected
with opsonized or non-opsonized, unlabeled or FITC-
labeled Mtb strains (wild-type, mutant [ΔkstD] or
complemented [ΔkstD- kstD]) at a multiplicity of infec-
tion (MOI) of 1 or 10, as indicated, for 2 hours (37°C,
5% CO2). Extracellular bacteria were removed by exten-
sively washing MØ with warm HBSS. Infected MØ were
directly used in tests (day 0) or cultured for 1, 2 or 6
days, as indicated in Figures.
Ingestion of bacteria
Resting MØ and IFN-γ-activated MØ (1 × 105 cells/
well) were prepared in 8-well Permanox chamber slides
(Nunc, Denmark) and then infected with FITC-labeled
Mtb strains at an MOI of 10. After infection, MØ were
fixed by incubating with 3% FA for 15 minutes (37°C,
5%, CO2) and washed twice with HBSS. The number of
infected MØ and the number of bacteria engulfed by
one MØ were determined by fluorescence microscopic
examination (Nikon ECLIPSE TE 2000 U). In all cases,
200 MØ were counted.
Intracellular growth of bacteria
Resting MØ and IFN-γ-activated MØ (1 × 105 cells/well)
were prepared in 24-well plates (Nunc). MØ were then
treated with 10 μM IRAK1/4 inhibitor or with a
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(35 μg/ml) for 1 hour or left untreated. Afterwards, MØ
were infected with Mtb strains at an MOI of 1. After in-
fection, fresh CM and IRAK1/4 inhibitor or anti-TLR2
blocking mAb (when required) were added, and cells
were cultured for 6 days. On the day of infection (day 0)
and 6 days post-infection, MØ were lysed with 1 ml of
0.2% Triton X-100 and appropriate dilutions of cell
lysates were plated onto Middlebrook 7H10 agar
supplemented with 10% OADC. After 21 days of culture,
CFUs were counted. The data were presented as fold-
increase in CFUs, calculated as CFUs on day 6 divided
by CFUs on day 0.NO production
Resting MØ and IFN-γ-activated MØ (1 × 105 cells/well)
were prepared in 96-well plates (Nunc) and treated with
IRAK1/4 inhibitor or left untreated (as described above).
Next, MØ were infected with Mtb strains at an MOI of
10 and cultured for 2 days with or without IRAK1/4 in-
hibitor. The presence of nitrite (stable metabolite of
NO) in the culture supernatants was determined using the
Griess reagent. OD was determined using a Multiscan RC
ELISA reader (Labsystem, Finland). Nitrite concentration
was calculated from a standard curve prepared using
sodium nitrite as a reference.ROS production
Resting MØ and IFN-γ-activated MØ (1 × 105 cells/well)
were prepared in 96-well plates (Nunc) and then
infected with Mtb strains at an MOI of 10. After cultur-
ing for 1 day, 1 μg/ml of PMA (to initiate ROS production)
as well as 40 U of HRP and 1 mM luminol (to enhance
chemiluminescence) were added to the cells. Chemilumin-
escence (CL) was recorded over 4 hours at 5-minute
intervals using Fluoroscan Ascent FL (Labsystem, Finland).
Data were acquired as relative light units (RLUs), and the
area under the curve of CL versus assay time (total RLUs)
was calculated. Data were presented as percent inhibition
of ROS production calculated according to the formula, 1 -
(total RLUs for cells infected with bacteria and
stimulated with PMA/total RLUs for cells stimulated
with PMA) × 100.TNF-α and IL-10 production
Resting MØ and IFN-γ-activated MØ (1 × 106 cells/well)
were prepared in 24-well plates (Nunc), infected with
Mtb strains (MOI of 10), and cultured for 24 hours. The
presence of TNF-α and IL-10 in the culture supernatants
was assessed using Quantikine ELISA kits. The sensitiv-
ities of TNF-α and IL-10 assays were 1.6 pg/ml and
3.9 pg/ml, respectively.Statistical analysis
Data are presented as means ± SEMs. Statistical signifi-
cance was verified using nonparametric Wilcoxon’s
signed-rank or Mann–Whitney U tests. The Statistica
8.0 (StatSoft, Poland) software package was used for stat-
istical calculations. Statistical significance was defined as
p ≤ 0.05.
Results
Expression of CD14 on resting MØ
In order to confirm that THP-1 cells in the presence of
PMA were differentiated after 24 hours, the surface ex-
pression of CD14 molecule was estimated. Similarly to
other researchers [17,18] we found that CD14 surface
expression on monocytes (i.e., THP-1 cells prior to dif-
ferentiation) was greater than on PMA-treated THP-1
cells (i.e., after differentiation to MØ), with MFI values
of 99 ± 10 and 45 ± 7 (n = 6), respectively.
MØ uptake of ΔkstD mutant and wild-type strains
The percentage of resting MØ and IFN-γ-activated MØ
involved in the uptake of Mtb strains was approximately
30-40%. Moreover, both types of MØ ingested opsonized
and non-opsonized wild-type and ΔkstD strains equally
well (Figure 1A), and took up similar numbers of bac-
teria of both strains (Figure 1B).
Intracellular replication of wild-type and ΔkstD strains
Initially, we compared the survival of the wild-type and
ΔkstD strains in resting MØ 1, 2, 4, 6 and 8 days post-
infection. The detachment of MØ monolayer was
observed on day 8 and therefore this time point was
excluded from the subsequent experiments. We did not
observe differences in CFUs count at 1 and 2 days post-
infection, therefore day 1 was also excluded from the
subsequent experiments. As shown in Figure 2, the
numbers of viable wild-type and ΔkstD bacilli were simi-
lar up to 2 days post-infection, slightly and insignifi-
cantly different up to 4 days and statistically different on
day 6, suggesting differential growth of mutant and wild-
type strains. To test this, we compared the intracellular
replication of ΔkstD and wild-type Mtb in resting and
IFN-γ-activated MØ 6 days after infection. We found
that survival of opsonized and non-opsonized wild-type
and ΔkstD strains was slightly but insignificantly differ-
ent in IFN-γ-activated MØ. In contrast, growth of mu-
tant strain was significantly attenuated in resting MØ
compared to wild-type and complemented (ΔkstD-kstD)
strains (Figure 3A). It should also be noticed that the
initial CFUs/ml values (day 0) for wild-type and mutant
strains did not differ statistically. CFUs/ml values of
opsonized and non-opsonized wild-type and ΔkstD
strains for IFN-γ-activated MØ amounted: 1425 ± 507;
3270 ± 1715 and 2550 ± 845; 2150 ± 556, respectively and
Figure 1 Ingestion of Mtb by MØ. Resting and IFN-γ-activated MØ were infected with FITC-labeled wild-type or ΔkstD strains for 2 hours. (A)
Percentage of MØ infected with Mtb strains; (B) Percentage distribution of MØ with the counted number of bacteria engulfed by one phagocyte
(per MØ). Percentage of infected MØ was calculated according to the formula: MØ with bacteria *100/ number of counted MØ and expressed as
means ± SEMs (n = 5). Mtb ops – bacteria opsonized, Mtb non-ops – bacteria non-opsonized.
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1950 ± 1177; 2760 ± 1250, respectively.
We found that TLR2 expression level on resting MØ
was higher than on monocytes and the treatment of MØ
with IFN-γ enhanced this expression (MFI = 115 ± 7 and
MFI = 71 ± 10, and MFI = 171 ± 13, respectively). By
using flow cytometry we found that surface expression
of TLR2 was virtually undetectable (MFI = 32 ± 5) after
pre-incubation of resting MØ and IFN-γ-activated MØ
with 35 μg/ml of blocking anti-TLR2 mAb.
The presence of IRAK1/4 inhibitor or anti-TLR2
blocking mAb insignificantly influenced the survival of
the wild-type strain in either type of MØ (Figure 3B). In
contrast, inhibition of the TLR2 signaling pathway sig-
nificantly increased the growth of both opsonized and
non-opsonized ΔkstD in resting MØ (Figure 3C).Dimethyl sulfoxide (DMSO), used as a vehicle to prepare
IRAK1/4 inhibitor solutions, had no effect on the growth
of Mtb strains in MØ at the final concentration present
in CM containing IRAK1/4 inhibitor (0.5%) (data not
shown).
ROS and NO production by MØ infected with wild-type,
ΔkstD, or ΔkstD-kstD strains
We next tested the influence of Mtb on spontaneous and
PMA-stimulated ROS production by MØ 1 day post-
infection. In a preliminary study, we noted that wild-type
Mtb did not affect spontaneous ROS production by MØ,
but strongly inhibited the ability of resting and IFN-
γ-activated MØ to produce ROS in response to PMA acti-
vation (data not shown). Therefore, in subsequent
experiments, we compared the effect of wild-type and
Figure 2 Time-dependent survival of Mtb in MØ. Resting MØ
were infected with wild-type or ΔkstD strains for 2 hours. On the day
of infection and after 2, 4 or 6 days in culture, MØ were lysed with
Triton X-100 and cell lysates were plated onto agar plates. After
21 days of culture, CFUs/ml were counted. The data are presented
as fold increase in CFUs/ml, expressed as means ± SEMs (n = 3). Mtb
ops – bacteria opsonized, Mtb non-ops – bacteria non-opsonized.
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IFN-γ-activated MØ in the presence of PMA. We found
that the production of ROS in IFN-γ-activated MØ was
inhibited to a similar extent by the ΔkstD mutant and the
wild-type strain. However, opsonized and non-opsonized
ΔkstD exhibited a significantly weaker ability to inhibit
ROS production in resting MØ compared to wild-type
and complemented strains (Figure 4). Two days post-
infection wild-type Mtb had significantly higher ability to
inhibit ROS production by resting MØ than mutant
strain. The percentage of inhibition of ROS production
induced with wild-type opsonized or non-opsonized and
ΔkstD mutant opsonized or non-opsonized amounted:
78 ± 7; 40 ± 8 and 33 ± 22; 34 ± 14, respectively. Neither
the vehicle control for PMA (0.1% ethanol in HBSS) nor
0.5% DMSO (in HBSS) affected ROS production by
resting MØ (17 and 20 RLU for ethanol and DMSO
solutions, respectively) or activated MØ (74 and 71 RLU
for ethanol and DMSO solutions, respectively).
Because preliminary experiments demonstrated that the
level of nitrite (a stable metabolite of NO) was almostundetectable in culture supernatants 1 day after infection,
NO production by MØ was determined on day 2 post-
infection. We found no significant differences in the
production of NO by IFN-γ-activated MØ (in which iNOS
expression is initiated by IFN-γ) infected with wild-type or
mutant strains. The level of nitrite in culture supernatants
of IFN-γ-activated MØ amounted 0.33 ± 0.10 μM for
uninfected MØ, 1.85 ± 0.65 μM and 1.98 ± 0.44 μM for
phagocytes infected with wild-type opsonized and non-
opsonized, respectively and 1.61 ± 0.59 μM and 2.33 ±
0.70 μM for phagocytes infected with ΔkstD strain
opsonized and non-opsonized, respectively. In contrast,
resting MØ produced significant amount of NO only after
infection with non-opsonized and opsonized ΔkstD strain
(Figure 5A). However, the difference observed in the
production of NO by resting MØ treated with opsonized
or non-opsonized ΔkstD mutant was statistically insignifi-
cant. The amount of nitrite in supernatants of uninfected
resting MØ was 0.40 ± 0.12 μM, in supernatants of resting
MØ infected with non-opsonized and opsonized wild-type
Mtb was 0.84 ± 0.2 μM and 0.90 ± 0.22 μM, respectively,
and infected with non-opsonized and opsonized mutant
strain was 1,24 ± 0.35 and 2.20 ± 0.53 μM, respectively.
Notably, NO production induced in mutant Mtb-infected
MØ was attenuated by treatment with IRAK1/4 inhibitor
(Figure 5B). As was the case for other parameters, DMSO
(0.5%) had no effect on NO production by resting or IFN-
γ-activated MØ (0.40 ± 0.2 μM vs. 0.37 ± 0.2 μM nitrite in
the presence and absence of DMSO, respectively).
TNF-α and IL-10 production by MØ infected with wild-
type, ΔkstD, or ΔkstD-kstD strains
We found no difference in the production of TNF-α
between resting and IFN-γ-activated MØ infected with
either wild-type or mutant strains (Figure 6A). Similarly,
resting MØ produced equal amounts of IL-10 in re-
sponse to the infection with wild-type Mtb or ΔkstD
strain. However, the ΔkstD strain, both opsonized and
non-opsonized, stimulated IFN-γ-activated MØ to re-
lease significantly higher amounts of IL-10 (20 ± 2 and
28 ± 6 pg/ml, respectively) than did wild-type (13 ± 2 and
15 ± 4 pg/ml, respectively) or complemented strains (12
± 4 and 14 ± 5 pg/ml, respectively) (Figure 6B). Further-
more, resting MØ infected with wild-type Mtb produced
higher amounts of IL-10 than did IFN-γ-activated MØ.
In the absence of Mtb infection, resting and IFN-γ
-activated MØ released relatively low amounts of TNF-α
(11.0 ± 3.0 and 8.2 ± 2.2 pg/ml for resting and activated
MØ, respectively) and IL-10 (1.3 ± 0.4 and 2.8 ± 0.3 pg/
ml for resting and activated MØ, respectively).
Discussion
It is well documented that Mtb metabolizes cholesterol,
though the role of this metabolism in pathogenicity
Figure 3 Survival of Mtb in MØ. (A) Resting MØ and IFN-γ-activated MØ were infected with wild-type, ΔkstD, or ΔkstD-kstD strains for 2 hours
without inhibitors. Resting MØ were pre-incubated with IRAK1/4 inhibitor or anti-TLR2 blocking mAb for 1 hour prior to infection with wild-type
(B) or ΔkstD (C) strains. On the day of infection and after 6 days in culture, MØ were lysed with Triton X-100 and cell lysates were plated onto
agar plates. After 21 days of culture, CFUs/ml were counted. The data are presented as fold increase in CFUs/ml, expressed as means ± SEMs
(n = 5; *p≤ 0.05, ΔkstD vs. wild-type or ΔkstD-kstD; #p ≤ 0.02, ΔkstD vs. ΔkstD + IRAK1/4 or ΔkstD + anti-TLR2 mAb; Mann–Whitney U test).
ops – bacteria opsonized, non-ops – bacteria non-opsonized.
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ability to transport or degrade cholesterol have been pre-
viously investigated in respect to possible attenuation of
the infection process. The deletion of mce4, which
affects cholesterol uptake by Mtb, attenuated the Δmce4
mutant in IFN-γ-stimulated, but not resting, mouse
bone marrow MØ [9]. Disruption of the gene encoding
3-ketosteroid 9α-hydrolase attenuated the growth ofΔkshA and ΔkshB mutants in both resting and IFN-γ
-activated, mouse bone marrow MØ [11]. The inhibition
of side chain degradation by inactivation of fadA5
decreased the virulence of mutant during the late stage
of mouse infection [19]. It was also previously shown
that Δigr knock-out strain of Mtb was attenuated in
mice during the early phase of infection [20]. The igr of
Mtb was identified as required for degradation of the
Figure 4 ROS production by infected MØ. Resting MØ and IFN-γ-activated MØ were infected with wild-type, ΔkstD, or ΔkstD-kstD strains for
2 hours and cultured for 1 day. Cells were then stimulated with PMA, and ROS production was assessed using the CL assay. Data are presented
as the percentage of ROS production inhibition, expressed as means ± SEMs (n = 5; *p≤ 0.04, ΔkstD vs. wild-type or ΔkstD-kstD; Mann–Whitney U
test). ops – bacteria opsonized, non-ops – bacteria non-opsonized.
Figure 5 NO production by infected MØ. (A) Resting MØ and IFN-γ-activated MØ were infected with wild-type, ΔkstD, or ΔkstD-kstD strains for
2 hours without inhibitors. (B) Resting MØ were pre-incubated with IRAK1/4 inhibitor for 1 hour prior to infection with ΔkstD. After culturing for
2 days, the concentration of nitrite, a stable metabolite of NO, was assessed in culture supernatants using the Griess reagent. The data are
presented as nitrite concentration, expressed as means (μM) ± SEMs (n = 6; *p≤ 0.03, strain vs. none [MØ in CM]; Wilcoxon’s signed-rank test).
ops – bacteria opsonized, non-ops – bacteria non-opsonized; none – MØ in culture medium (control).
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Figure 6 TNF-α and IL-10 production by infected MØ. Resting MØ and IFN-γ-activated MØ were infected with wild-type, ΔkstD, or ΔkstD-kstD
strains for 2 hours and then cultured for 1 day. The amount of released TNF-α (A) and IL-10 (B) was assessed in culture supernatants using ELISA
kits. Data are presented as means (pg/ml) ± SEMs (n = 5; *p ≤ 0.02, ΔkstD vs. wild-type or ΔkstD-kstD; Mann–Whitney U test). ops – bacteria
opsonized, non-ops – bacteria non-opsonized.
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data suggest that ability of Mtb to catabolize cholesterol
is important during both early and late stages of the in-
fection. In contrast, Yang et al. [23] reported that repli-
cation rates of wild-type Mtb CDC1551 and its mutant
Δhsd were similar in the lungs of guinea pigs and
concluded that cholesterol was not an essential source
of nutrient for Mtb during infection. On the other hand,
Mtb H37Rv Δhsd mutant (as well as double mutant
ΔhsdΔchoD) were able to utilize cholesterol suggesting
that both HsdD and ChoD are not essential for choles-
terol degradation [13]. All above-mentioned examples
described the activity of Mtb mutants in animal models.
However, the intracellular replication of mutants defect-
ive in the ability to degrade cholesterol and their effects
on the functional activity of human MØ are less well
understood. Therefore, the aim of our study was to de-
termine whether the ΔkstD mutant can multiply in
human MØ and assess its capacity to modify the func-
tional activity of the phagocytes. As we demonstrated
previously, KstD is an essential enzyme in the metabol-
ism of cholesterol by Mtb; therefore, the ΔkstD strain isunable to use cholesterol as a primary source of carbon
and energy, and accumulates the non-toxic derivatives of
cholesterol, AD and 9OHAD. Moreover, the in vitro
growth of ΔkstD strain is not affected in rich medium
compared to the wild type [10].
Herein, we found that the lack of a functional kstD
gene did not influence the ability of resting or IFN-γ
-activated MØ to ingest Mtb. However, we observed that
the intracellular replication of ΔkstD mutant was
attenuated in both resting (statistically significant) and
IFN-γ-activated (statistically insignificant) MØ compared
to the wild-type strain. The attenuation of cholesterol
degradation mutants was previously observed in IFN-γ
-activated MØ [9,11]. Our data suggest that cholesterol
degradation ability is important for Mtb at multiple
stages of the infection in resting and IFN-γ-activated
MØ. The significant attenuation of the mutant observed
in our study in resting MØ may result from experimen-
tal model used - human cell line THP-1.
Tubercle bacilli after penetration into MØ reside pre-
dominantly in a cholesterol rich region of cell plasma
membrane and the ability of Mtb to degrade cholesterol
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However, it is unclear whether the only reason of attenu-
ation of cholesterol degradation mutants in MØ is due
to their inability to use cholesterol as a source of carbon
and energy. It was previously found that a mutant
lacking an intact hsaC gene accumulated catechol
derivatives that appeared to be toxic to Mtb [12]. The
attenuated growth of the ΔkstD mutant in resting MØ,
used in the current study, was not due to the accumula-
tion of toxic compounds, suggesting that cholesterol
degradation ability per se is essential for the replication
of tubercle bacilli inside MØ [10]. On the other hand,
the lack of a functional copy of kstD might modify the
basic metabolism affecting pathogenic features of the ba-
cilli. The mutant ΔkshB revealed unusual change in the
structure of the cell wall which was thickened and
loosened as a result of the synthesis of lipid types other
than those in wild-type Mtb [11]. Such modification of
the cell envelope can influence the pathogenicity of Mtb.
It was also suggested that cholesterol metabolism of
Mtb may contribute to the production of specific viru-
lence factors and/or disruption of host cell signa-
ling [24].
Moreover, the in vivo cholesterol degradation by Mtb
can affect the activity of MØ. In our studies the ΔkstD
failed to inhibit ROS and NO production in resting MØ
compared to wild-type and complemented strains. It is
generally accepted that ROS and RNIs kill or inhibit
intracellular growth of Mtb [8,25,26]. Similar to previous
report [27], we found that Mtb induced ROS production
in MØ immediately after phagocytosis (data not shown).
The increased oxidative response in MØ infected with
ΔkstD unable to metabolize cholesterol can be directly
related to cholesterol degradation process (e.g. if choles-
terol metabolite modifies the signaling of enzymes
involved in NO and ROS production) or can be a deriva-
tive of attenuation of bacilli inside MØ. To clarify this
issue we used two different Mtb mutants, not related to
cholesterol degradation process and showing attenuated
growth in THP-1, to test them in respect to inhibition of
ROS/NO production in macrophages (data not shown).
Only one of them was able to inhibit ROS/NO produc-
tion to the level of the wild type strain. Therefore the
most likely interpretation of our result is that ROS/NO
over-production in resting MØ infected with ΔkstD
results from the attenuation of the mutant’s growth in-
side MØ, however the specific role of cholesterol deg-
radation intermediates cannot be excluded. Changes in
the cholesterol level in plasma membrane modulate the
activity of the proteins and the receptors located in the
lipid rafts. The components of NADPH oxidase are
known to migrate to the plasma membrane of newly
formed phagosome. The recruitment of NADPH oxidase
subunits and their assembly in the membrane arenecessary for an oxidative burst execution [28]. It was
found that methyl-β-cyclodextrin, a chelating agent of
cholesterol, inhibited H2O2 production by neutrophils
and in the absence of lipid rafts neutrophil NADPH oxi-
dase activity was changed [29].
We did not observe differences in oxidative response
in IFN-γ induced MØ infected with wild type and mu-
tant strains. However, the IFN-γ induces iNOS expres-
sion initiating the production of NO by MØ prior to
their infection with Mtb (data not shown). The high
level of NO reached in IFN-γ treated MØ cannot be
subsequently lowered even by wild type Mtb at least
within the period of the experiment. Therefore, IFN-γ
-activated MØ produced a similar, high amount of NO
in response to the infection with wild-type or mutant
strains.
Phagocytosis of Mtb initiates the production of both
TNF-α and IL-10 by MØ. It has been demonstrated by
others that TNF-α together with IFN-γ participate in the
killing of Mtb through the induction of NO and ROS
production. TNF-α is also essential for granuloma for-
mation [30-32]. We found here that the infection of
resting and INF-γ-activated MØ with wild-type Mtb or
ΔkstD mutant caused the release of equal amounts of
TNF-α. At the same time however, we observed a
greater increase in the production of IL-10 by IFN-γ
-activated MØ infected with the ΔkstD strain compared
to those infected with the wild-type or complemented
strains. It has been reported that pathogenic strains of
Mtb stimulate lower levels of TNF-α production by MØ
than non-pathogenic species [32]. IL-10 is an immuno-
suppressive cytokine that blocks phagosome maturation
and antigen presentation and also limits the Th1 re-
sponse [33]. Thus, our finding that MØ infected with
the ΔkstD strain produce higher level of IL-10 than MØ
infected with wild-type Mtb and that similar amount of
TNF-α is released by MØ after infection with both
strains may suggest that certain aspects of the virulence
activity of the wild-type strain are in fact not affected in
the ΔkstD mutant.
Interestingly, we found that blocking the TLR2-
mediated signaling pathway prior to infection restored
the phenotype of the ΔkstD mutant in resting MØ to a
level similar to that of the wild-type strain. However,
neither anti-TLR2 blocking mAb nor IRAK1/4 inhibitor
altered the response of MØ to wild-type Mtb. These
results suggest that TLR2 signaling is disrupted in MØ
infected with wild-type Mtb, but not in MØ infected
with the mutant strain. The essential role of the TLR2-
mediated pathway in the production of NO and ROS in
Mtb-infected MØ is well documented [5,6,26,34]. Fur-
ther study is needed to elucidate the complete mechan-
ism by which Mtb affects TLR2 signaling whether the
ability of Mtb to catabolize cholesterol might be
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by others that Mtb is able to modulate macrophage
signaling pathways by stimulating phosphorylation of
the Bcl-2 family member Bad as well as AKT kinase
[35]. AKT kinase serves a pro-survival function by
inhibiting apoptotic processes [36], whereas Bad is a
pro-apoptotic member of Bcl-2 family involved in
initiating apoptosis [37].
Conclusions
Our results indicate that the degradation of cholesterol
is required for Mtb to survive during infection in resting
macrophages. A mutant lacking a functional copy of the
kstD gene showed a limited ability to multiply inside
resting MØ. Moreover, the bactericidal activity of resting
MØ was not inhibited by the infection with the ΔkstD
mutant strain. Collectively, these findings indicate a rela-
tionship between degradation of cholesterol by Mtb,
Mtb survival in MØ, and functional responses of Mtb-
infected MØ.
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